Eyenovia Stock Price Prediction

EYEN Stock  USD 0.11  0.02  19.05%   
As of today, the relative strength index (RSI) of Eyenovia's share price is approaching 45 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Eyenovia, making its price go up or down.

Oversold Vs Overbought

45

 
Oversold
 
Overbought
The successful prediction of Eyenovia's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Eyenovia, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Eyenovia's stock price prediction:
EPS Estimate Next Quarter
(0.11)
EPS Estimate Current Year
(0.59)
EPS Estimate Next Year
(0.41)
Wall Street Target Price
3.5
EPS Estimate Current Quarter
(0.13)
Using Eyenovia hype-based prediction, you can estimate the value of Eyenovia from the perspective of Eyenovia response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Eyenovia to buy its stock at a price that has no basis in reality. In that case, they are not buying Eyenovia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Eyenovia after-hype prediction price

    
  USD 0.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Eyenovia Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eyenovia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.010.1111.66
Details
4 Analysts
Consensus
LowTargetHigh
10.6211.6712.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.15-0.15-0.14
Details

Eyenovia After-Hype Price Prediction Density Analysis

As far as predicting the price of Eyenovia at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eyenovia or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eyenovia, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Eyenovia Estimiated After-Hype Price Volatility

In the context of predicting Eyenovia's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eyenovia's historical news coverage. Eyenovia's after-hype downside and upside margins for the prediction period are 0.01 and 11.66, respectively. We have considered Eyenovia's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.11
0.11
After-hype Price
11.66
Upside
Eyenovia is out of control at this time. Analysis and calculation of next after-hype price of Eyenovia is based on 3 months time horizon.

Eyenovia Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Eyenovia is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eyenovia backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eyenovia, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.37 
11.55
  0.01 
 0.00  
10 Events / Month
12 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.11
0.11
0.00 
115,500  
Notes

Eyenovia Hype Timeline

Eyenovia is currently traded for 0.11. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. Eyenovia is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -1.37%. %. The volatility of related hype on Eyenovia is about 2194500.0%, with the expected price after the next announcement by competition of 0.11. About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Eyenovia was currently reported as 0.2. The company recorded a loss per share of 0.69. Eyenovia had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days.
Check out Eyenovia Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.

Eyenovia Related Hype Analysis

Having access to credible news sources related to Eyenovia's direct competition is more important than ever and may enhance your ability to predict Eyenovia's future price movements. Getting to know how Eyenovia's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eyenovia may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RVPHReviva Pharmaceuticals Holdings(0.13)6 per month 5.60  0.1  10.71 (9.86) 38.61 
CDTXCidara Therapeutics(0.16)10 per month 2.15  0.11  5.60 (3.77) 17.09 
FBIOFortress Biotech(0.06)9 per month 0.00 (0.09) 7.43 (5.08) 26.13 
RVPHWReviva Pharmaceuticals Holdings(0.04)3 per month 16.17  0.13  28.57 (32.83) 129.53 
CGTXCognition Therapeutics 0.04 8 per month 0.00 (0.11) 8.89 (10.34) 36.32 
RNAZTranscode Therapeutics 0.04 2 per month 6.58  0.08  22.00 (11.43) 68.80 
KODKodiak Sciences(0.04)6 per month 2.85  0.25  9.70 (4.92) 18.79 
BLRXBioLineRx(0.02)4 per month 0.00 (0.16) 4.88 (6.67) 17.74 
ARDXArdelyx 0.62 11 per month 0.00 (0.08) 4.96 (6.13) 33.99 
LXRXLexicon Pharmaceuticals(0.07)6 per month 0.00 (0.22) 5.24 (7.55) 46.58 
MCRBSeres Therapeutics 0.03 10 per month 0.00 (0.03) 10.00 (9.78) 26.87 
IBRXImmunitybio 0.38 10 per month 4.49  0.04  13.00 (7.80) 35.54 
DRTSAlpha Tau Medical(0.09)5 per month 2.24  0  5.41 (3.78) 13.41 
OCULOcular Therapeutix 0.38 10 per month 0.00 (0.05) 6.07 (5.33) 19.78 
TNYATenaya Therapeutics(0.17)6 per month 0.00 (0.05) 10.40 (6.88) 38.23 
INZYInozyme Pharma(0.16)8 per month 0.00 (0.29) 5.68 (7.92) 16.62 
GLSIGreenwich Lifesciences 0.27 6 per month 0.00 (0.08) 5.23 (4.90) 16.03 
IMMPImmutep Ltd ADR 0.06 4 per month 0.00 (0.13) 5.02 (5.56) 18.55 
AVXLAnavex Life Sciences(0.87)10 per month 3.40  0.11  10.31 (7.22) 30.62 

Eyenovia Additional Predictive Modules

Most predictive techniques to examine Eyenovia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eyenovia using various technical indicators. When you analyze Eyenovia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Eyenovia Predictive Indicators

The successful prediction of Eyenovia stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eyenovia, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eyenovia based on analysis of Eyenovia hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eyenovia's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eyenovia's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding56.0260.2K54.2K56.9K
PTB Ratio5.143.189.4815.46

Story Coverage note for Eyenovia

The number of cover stories for Eyenovia depends on current market conditions and Eyenovia's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eyenovia is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eyenovia's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Eyenovia Short Properties

Eyenovia's future price predictability will typically decrease when Eyenovia's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eyenovia often depends not only on the future outlook of the potential Eyenovia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eyenovia's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding41 M
Cash And Short Term Investments14.8 M
When determining whether Eyenovia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eyenovia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eyenovia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eyenovia Stock:
Check out Eyenovia Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.001
Quarterly Revenue Growth
4
Return On Assets
(0.93)
Return On Equity
(9.15)
The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.